Cardiac device-related infective endocarditis need for lead extraction whatever the device according to the ESC EORP EURO-ENDO registry
European Heart Journal Open · 03.07.2023 · 3 (4)
DOI: 10.1093/ehjopen/oead064 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Heart Journal Open, online erschienen am 03.07.2023. Verfasst von Erwan Donal und 18 weiteren Autor:innen. Beteiligte Einrichtung: Cardiologie, CHU de RENNES, LTSI UMR1099, INSERM, Université de Rennes-1, hopital pontchaillou, 35000 Rennes, France. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Abbott Vascular Int, Amgen Cardiovascular, AstraZeneca.
Abstract (Originalsprache)
Aims
Cardiac device–related infective endocarditis (CDRIE) is a severe complication of cardiac device (CD) implantation and is usually treated by antibiotic therapy and percutaneous device extraction. Few studies report the management and prognosis of CDRIE in real life. In particular, the rate of device extraction in clinical practice and the management of patients with left heart infective endocarditis (LHIE) and an apparently non-infected CD (LHIE+CDRIE−) are not well described. Methods and results We sought to study in EURO-ENDO, the characteristics, prognosis, and management of 483 patients with a CD included in the European Society of Cardiology EurObservational Research Programme EURO-ENDO registry. Three populations were compared: 280 isolated CDRIE (66.7 ± 14.3 years), 157 patients with LHIE and an apparently non-infected CD (LHIE+CDRIE−) (71.1 ± 13.6), and 46 patients with both LHIE and CDRIE (LHIE+CDRIE+) (70.2 ± 10.1). Echocardiography was not always transoesophageal echography (TOE); it was transthoracic echography (TTE) for isolated CDRIE in 88.4% (TOE = 67.6%), for LHIE+CDRIE− TTE = 93.0% (TOE = 58.6%), and for CDRIE+LHIE+ TTE = 87.0% (TOE = 63.0%). Nuclear imaging was performed in 135 patients (positive for 75.6%). In-hospital mortality was lower in isolated CDRIE 13.2% vs. 22.3% and 30.4% for LHIE+CDRIE− and LHIE+CDRIE+ (P = 0004). Device extraction was performed in 62.1% patients with isolated CDRIE, 10.2% of LHIE+CDRIE− patients, and 45.7% of CDRIE+LHIE+ patients. Device extraction was associated with a better prognosis [hazard ratio 0.59 (0.40–0.87), P = 0.0068] even in the LHIE+CDRIE− group (P = 0.047).
Conclusion
Prognosis of endocarditis in patients with a CD remains poor, particularly in the presence of an associated LHIE. Although recommended by guidelines, device extraction is not always performed. Device removal was associated with better prognosis, even in the LHIE+CDRIE− group.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Cardiologie, CHU de RENNES, LTSI UMR1099, INSERM, Université de Rennes-1, hopital pontchaillou, 35000 Rennes, France.
- Department of Cardiology, Amiens University Hospital Amiens, Amiens 80000, France.
- Echocardiography Research Centre, Rajaie Cardiovascular Medical and Research Centre, Iran University of Medical Sciences, Tehran, Iran.
- European Society of Cardiology, EORP, Sophia-Antipolis, France.
- servico de Echocardiografia-InRad-HC-Faculdade de Medicina, Universidade de Sao Paulo, SP, Brazil.
- Serviço de Cardiologia e Cirurgia Cardiovascular e Centro de Telessaúde, Hospital das Clínicas da Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil.
ORCID-Profile: Erwan Donal, Christophe Tribouilloy, Anita Sadeghpour, Duk-Hyun Kang, Marta Hernadez-Meneses, Zhanna Kobalava, Michele De Bonis, Rafal Dworakowski, Branislava Ivanovic, Maria Holicka, Takeshi Kitai, Ines Cruz, Olivier Huttin, Paolo Colonna, Patrizio Lancellotti, Gilbert Habib
Förderung
- Abbott Vascular Int
- Amgen Cardiovascular
- AstraZeneca
- Bayer AG
- Boehringer Ingelheim
- Boston Scientific
- Bristol Myers Squibb
- Pfizer Alliance
Zitieren
APA
Donal, E., Tribouilloy, C., Sadeghpour, A., Laroche, C., Tude Rodrigues, A. C., Pereira Nunes, M. D. C., Kang, D. H., Hernadez-Meneses, M., Kobalava, Z., De Bonis, M., Dworakowski, R., Ivanovic, B., Holicka, M., Kitai, T., Cruz, I., Huttin, O., Colonna, P., Lancellotti, P., & Habib, G. (2023). Cardiac device-related infective endocarditis need for lead extraction whatever the device according to the ESC EORP EURO-ENDO registry. European Heart Journal Open, 3(4). https://doi.org/10.1093/ehjopen/oead064
Vancouver
Donal E, Tribouilloy C, Sadeghpour A, Laroche C, Tude Rodrigues AC, Pereira Nunes MDC, et al. Cardiac device-related infective endocarditis need for lead extraction whatever the device according to the ESC EORP EURO-ENDO registry. European Heart Journal Open. 2023;3(4). doi:10.1093/ehjopen/oead064
BibTeX
@article{Donal2023,
author = {Donal, Erwan and Tribouilloy, Christophe and Sadeghpour, Anita and Laroche, Cécile and Tude Rodrigues, Ana Clara and Pereira Nunes, Maria do Carmo and Kang, Duk-Hyun and Hernadez-Meneses, Marta and Kobalava, Zhanna and De Bonis, Michele and Dworakowski, Rafal and Ivanovic, Branislava and Holicka, Maria and Kitai, Takeshi and Cruz, Ines and Huttin, Olivier and Colonna, Paolo and Lancellotti, Patrizio and Habib, Gilbert},
title = {Cardiac device-related infective endocarditis need for lead extraction whatever the device according to the ESC EORP EURO-ENDO registry},
journal = {European Heart Journal Open},
year = {2023},
volume = {3},
number = {4},
doi = {10.1093/ehjopen/oead064}
}
EUVIMED